Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CERo Therapeutics Holdings, Inc. - Common Stock (NQ: CERO )

0.2181 -0.0298 (-12.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CERo Therapeutics Holdings, Inc. - Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
Via Benzinga
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Why Domino's Pizza Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
CERo Therapeutics Stock Is Soaring Monday: What's Going On?
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound. 
Via Benzinga
Nasdaq Moves Lower; Canaan Shares Surge
Via Benzinga
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics, Inc. Provides Corporate Update
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Falls Over 50 Points; Cintas Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
CERO Stock Earnings: CERo Therapeutics Hldgs Reported Results for Q2 2024
CERo Therapeutics Hldgs just reported results for the second quarter of 2024. 
Via InvestorPlace
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Gains 1%; McDonald's Posts Downbeat Results
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning! 
Via InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.